New Therapeutic Options for Acute and Chronic Hyperkalemia
Target Audience:
Cardiologists, residents, internists, pharmacists, nurse practitioners, nurses and other healthcare professionals involved in the management of patients with hyperkalemia
Program Overview:
This interactive CME/CE program will highlight new therapeutic options for acute and chronic hyperkalemia. The expert faculty, led by Dr. Charles V. Pollack Jr., will first provide an introduction and state of the science of hyperkalemia, including risk assessment and disease burden. Recent trial data of both emerged and emerging agents for the treatment of acute and chronic hyperkalemia will be reviewed, and clinical relevance debated through an interactive panel format. The expert faculty will conclude with a review of the role of the interprofessional team in personalized medicine to improve outcomes and quality of life for patients with acute and chronic hyperkalemia.
Agenda:
I. Registration and Dinner
II. Introduction and Case Presentations – Charles V. Pollack Jr., MD
III. Hyperkalemia Risk and Disease Burden– Debbie Castner, RN, MSN, APRN, CNN, NP
IV. A Clinical Analysis of Trial Data for the Treatment of Acute and Chronic Hyperkalemia – Matthew R. Weir, MD
V. Interactive Panel Discussion
VI. Optimal Individual Treatment Strategies for Special Populations with Hyperkalemia – Javed Butler, MD, MPH, MBA
VII. Interactive Panel Discussion
Faculty:
Charles V. Pollack Jr., MD
Founding Board Member
Hospital Quality Foundation
Shrewsbury, New Jersey
Javed Butler, MD, MPH, MBA
Chairman and Professor
Department of Medicine
University of Mississippi Medical Center
Jackson, Mississippi
Debbie Castner, RN, MSN, APRN, CNN, NP
Nurse Practitioner
Jersey Coast Nephrology & Hypertension Associates
Toms River, New Jersey
Matthew R. Weir, MD
Professor and Director
Division of Nephrology
University of Maryland School of Medicine
Baltimore, Maryland
Accreditation Statement:
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements:
AcademicCME designates this live material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AcademicCME designates this live material for a maximum of 2.0 CNE contact hours. AcademicCME’s ANCC provider number is P0491.
CE Inquiries/Special Needs:
For all CE inquiries or special needs, please contact [email protected] or 610-687-3300.
Financial Support:
This activity has been supported by an independent educational grant from AstraZeneca Pharmaceuticals.
Provided by AcademicCME
*This event is not part of the official Scientific Sessions 2019 as planned by the AHA Committee on Scientific Sessions Program.
